Sign In

Alan Murray

Founder at TMRW Life Sciences & Co-CEO at Conceivable Life Sciences

Alan Murray, alongside Joshua Abram, co-founded a series of successful venture-backed companies over the past 20 years.

Their expertise lies in creating new categories in technology, hospitality, and life sciences, leading to the establishment of firms like Integral Ad Science, NeueHouse, and TMRW Life Sciences.

As Coriolis Founders, they are not only known for their entrepreneurial ventures but also for early-stage investing in startups that later saw successful acquisitions by major firms like AT&T and Expedia.

Their recent focus has been on investing in disruptive fertility technologies, with their portfolio companies reaching a collective market value exceeding $5 billion by December 2021.

Alan and Joshua have received recognition from various publications including Architectural Digest, Forbes, and The Wall Street Journal for their innovative contributions.

Alan Murray's educational background includes a Bachelor's degree in Civil Engineering from the University of Kentucky.

He has held key roles in organizations such as Conceivable Life Sciences, TMRW Life Sciences, NeueHouse, and Integral Ad Science, showcasing his versatility and experience in the business world.

Highlights

Dec 15 · linkedin

Excited to announce our funding of a new fertility innovation company, Conceivable Life Sciences. Conceivable will introduce remarkable new robotic single cell manipulation instruments to the IVF process. This innovation unlocks the potential to help 10 million IVF families a year—a 10X expansion over what’s possible now using today’s manual laboratory processes.

Conceivable is highly complementary to the work being done by our extraordinary team at TMRW Life Sciences. We have no doubt that TMRW will triumph in introducing technology developed by Conceivable to existing IVF labs. We could have no better partner.

Conceivable and TMRW are at the vanguard of innovation, jointly leading a tech revolution that will make IVF safer, less expensive and more accessible for hundreds of millions of IVF patients worldwide in the years to come.

Special thanks to Aike Ho of ACME Ventures, Fred Destin of Stride.VC, Chris Kaster of Cadence Ventures and Tara Bishop MD, MPH, FACP of Black Opal Ventures and our other investors for their support.

#fertility #ivf #innovation #accessibility #family

Alan Murray
Add to my network

Location

New York, New York, United States